Home > Annual Financials > ROSSARI BIOTECH

ROSSARI BIOTECH Financial Statement Analysis
[BOM: 543213|NSE : ROSSARI]

The Revenues of ROSSARI BIOTECH have increased by 15.19% YoY .
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 9.38 % YoY.
COMMUNITY POLL
for ROSSARI BIOTECH
Please provide your vote to see the results

ROSSARI BIOTECH Last 5 Annual Financial Results
[BOM: 543213|NSE : ROSSARI]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹2,396 Cr₹2,080 Cr₹1,831 Cr₹1,656 Cr₹1,483 Cr
Expenses ₹2,127 Cr₹1,826 Cr₹1,587 Cr₹1,441 Cr₹1,307 Cr
Operating Profit (Excl OI) ₹269 Cr₹254 Cr₹243 Cr₹215 Cr₹176 Cr
Other Income ₹39 Cr₹15 Cr₹14 Cr₹14 Cr₹19 Cr
Interest ₹29 Cr₹18 Cr₹19 Cr₹22 Cr₹13 Cr
Depreciation ₹79 Cr₹67 Cr₹60 Cr₹63 Cr₹48 Cr
Profit Before Tax ₹203 Cr₹185 Cr₹178 Cr₹144 Cr₹136 Cr
Profit After Tax ₹149 Cr₹136 Cr₹131 Cr₹107 Cr₹98 Cr
Consolidated Net Profit ₹149 Cr₹136 Cr₹131 Cr₹107 Cr₹98 Cr
Earnings Per Share (Rs)₹26.94₹24.63₹23.66₹19.45₹17.74
PAT Margin (%)6.206.547.116.456.56
ROE(%)11.8812.2513.3612.5216.17
ROCE(%)14.8416.0718.3918.4824.37
Total Debt/Equity(x)0.310.160.100.080.01

Key Financials

Market Cap : ₹ 2,780.8 Cr
Revenue (TTM) : ₹ 2,549.9 Cr
Net Profit(TTM) : ₹ 148.9 Cr
EPS (TTM) : ₹ 26.9
P/E (TTM) : 18.7

Industry Peers & Returns1W1M1Y
ROSSARI BIOTECH -1.6% -7.4% -24.3%
SOLAR INDUSTRIES INDIA 6.4% 8.6% 36.2%
PIDILITE INDUSTRIES 1.8% 8.4% 10.5%
SRF -0% -9.6% -10.4%
GUJARAT FLUOROCHEMICALS 5.8% 15% 31.1%
GODREJ INDUSTRIES -3.3% -6.8% 13.2%
NAVIN FLUORINE INTERNATIONAL 0.4% 7.6% 67.3%
DEEPAK NITRITE -3.2% -1.1% -6.8%
ATUL -1.7% 10.1% 4.1%


ROSSARI BIOTECH Revenues
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

15.19 %

5 Yr CAGR

12.75 %

Years Revenues % Change
Mar2026 ₹2,396 Cr
15.19
Mar2025 ₹2,080 Cr
13.64
Mar2024 ₹1,831 Cr
10.55
Mar2023 ₹1,656 Cr
11.66
Mar2022 ₹1,483 Cr -


ROSSARI BIOTECH Operating Profit
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

5.85 %

5 Yr CAGR

11.15 %

Years Operating Profit % Change
Mar2026 ₹269 Cr
5.85
Mar2025 ₹254 Cr
4.57
Mar2024 ₹243 Cr
13.29
Mar2023 ₹215 Cr
21.70
Mar2022 ₹176 Cr -

Operating Margins
Y-o-Y

-8.10 %

5 Yr CAGR

-1.42 %

Years Operating Margin% % Change
Mar2026 11.23%
-8.10
Mar2025 12.22%
-7.98
Mar2024 13.28%
2.47
Mar2023 12.96%
9.00
Mar2022 11.89% -

ROSSARI BIOTECH Profit After Tax
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

9.41 %

5 Yr CAGR

11.17 %

Years Profit After Tax % Change
Mar2026 ₹149 Cr
9.41
Mar2025 ₹136 Cr
4.35
Mar2024 ₹131 Cr
21.85
Mar2023 ₹107 Cr
9.81
Mar2022 ₹98 Cr -

PAT Margins
Y-o-Y

-5.20 %

5 Yr CAGR

-1.40 %

Years PAT Margin(%) % Change
Mar2026 6.2 %
-5.20
Mar2025 6.54 %
-8.02
Mar2024 7.11 %
10.23
Mar2023 6.45 %
-1.68
Mar2022 6.56 % -

ROSSARI BIOTECH Earnings Per Share (EPS)
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

9.38 %

5 Yr CAGR

11.01 %

Years EPS % Change
Mar2026 ₹27
9.38
Mar2025 ₹25
4.10
Mar2024 ₹24
21.65
Mar2023 ₹19
9.64
Mar2022 ₹18 -

ROSSARI BIOTECH Return on Capital Employed (ROCE)
[BOM: 543213|NSE : ROSSARI]

Y-o-Y

-7.65 %

5 Yr CAGR

-11.66 %

Years ROCE % Change
Mar2026 14.84%
-7.65
Mar2025 16.07%
-12.62
Mar2024 18.39%
-0.49
Mar2023 18.48%
-24.17
Mar2022 24.37% -

ROSSARI BIOTECH Share Price vs Sensex

Current Share Price : ₹502.0
Current MarketCap: ₹ 2,780.8 Cr
Updated EOD on :Aug 14,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
ROSSARI BIOTECH

-1.6%

-7.4%

-24.3%

SENSEX

-0.6%

1.1%

-3.2%

ROSSARI BIOTECH related INDICES

BSE Indices1W1M1Y
BSE 1000 -0.3% 1.7% 4.4%
BSE COMMODITIES -1.5% 1.9% 11.2%
No NSE index found

You may also like the below Video Courses


FAQ about ROSSARI BIOTECH Financials


How the annual revenues of ROSSARI BIOTECH have changed ?

The Revenues of ROSSARI BIOTECH have increased by 15.19% YoY .

How the Earnings per Share (EPS) of ROSSARI BIOTECH have changed?

The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 9.38 % YoY .